PW MEDTECH GROUP DL-0001 - Asset Resilience Ratio

Latest as of December 2025: 0.10%

PW MEDTECH GROUP DL-0001 (PWE) has an Asset Resilience Ratio of 0.10% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore PWE total asset value for the complete picture of this company's asset base.

Liquid Assets

€5.00 Million
≈ $5.85 Million USD Cash + Short-term Investments

Total Assets

€5.24 Billion
≈ $6.12 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how PW MEDTECH GROUP DL-0001's Asset Resilience Ratio has changed over time. See PWE equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down PW MEDTECH GROUP DL-0001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PWE market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €5.00 Million 0.1%
Total Liquid Assets €5.00 Million 0.10%

Asset Resilience Insights

  • Limited Liquidity: PW MEDTECH GROUP DL-0001 maintains only 0.10% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

PW MEDTECH GROUP DL-0001 Industry Peers by Asset Resilience Ratio

Compare PW MEDTECH GROUP DL-0001's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
Medical Instruments & Supplies 26.12%
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
Medical Instruments & Supplies 38.45%
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 19.74%
IVF Hartmann Holding AG
SW:VBSN
Medical Instruments & Supplies 52.05%
Dentium
KO:145720
Medical Instruments & Supplies 1.23%
Medeon Biodesign
TWO:6499
Medical Instruments & Supplies 7.38%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%

Annual Asset Resilience Ratio for PW MEDTECH GROUP DL-0001 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for PW MEDTECH GROUP DL-0001.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.10% €5.00 Million
≈ $5.85 Million
€5.24 Billion
≈ $6.12 Billion
0.00pp
2024-12-31 0.10% €5.15 Million
≈ $6.02 Million
€5.16 Billion
≈ $6.03 Billion
+0.00pp
2023-12-31 0.10% €4.90 Million
≈ $5.73 Million
€5.15 Billion
≈ $6.02 Billion
-0.02pp
2022-12-31 0.11% €5.63 Million
≈ $6.58 Million
€4.99 Billion
≈ $5.83 Billion
-3.13pp
2021-12-31 3.24% €127.00 Million
≈ $148.48 Million
€3.92 Billion
≈ $4.58 Billion
--
pp = percentage points

About PW MEDTECH GROUP DL-0001

F:PWE Germany Medical Instruments & Supplies
Market Cap
$190.34 Million
€162.81 Million EUR
Market Cap Rank
#17423 Global
#1644 in Germany
Share Price
€0.11
Change (1 day)
-0.88%
52-Week Range
€0.09 - €0.18
All Time High
€0.18
About

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infus… Read more